Europe Anaphylaxis Treatment Market to Grow at a CAGR of 9.2% to reach US$ 987.2 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Anaphylaxis Treatment Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Anaphylaxis Treatment Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising Incidence of Anaphylaxis
5.1.3 Growing awareness and education about anaphylaxis management among healthcare providers and patients.
5.1.4 Advancements in auto-injector technologies improving accessibility and ease of use for emergency treatment.

5.2 Market Opportunities

5.2.1
5.2.2 Development of new formulations and delivery systems for more effective anaphylaxis treatments.
5.2.3 Expansion of training programs and resources for schools and workplaces to improve preparedness for anaphylaxis incidents.
5.2.4 Opportunities for partnerships between pharmaceutical companies and healthcare organizations for awareness campaigns and product distribution.

5.3 Future Trends

5.3.1
5.3.2 Increasing focus on personalized medicine approaches for allergy management and anaphylaxis prevention.
5.3.3 Integration of digital health technologies, such as mobile apps, for tracking and managing allergic reactions.
5.3.4 Growing emphasis on research and development for novel therapies targeting underlying causes of allergies.

5.4 Impact of Drivers and Restraints

6. Europe Anaphylaxis Treatment Market Regional Analysis

6.1 Europe Anaphylaxis Treatment Market Overview

6.2 Europe Anaphylaxis Treatment Market Revenue 2019-2028 (US$ Million)

6.3 Europe Anaphylaxis Treatment Market Forecast Analysis

7. Europe Anaphylaxis Treatment Market Analysis – by Medication Type

7.1 Epinephrine

7.1.1 Overview
7.1.2 Epinephrine: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Antihistamines

7.2.1 Overview
7.2.2 Antihistamines: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Steroids

7.3.1 Overview
7.3.2 Steroids: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Beta-Agonist

7.4.1 Overview
7.4.2 Beta-Agonist: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Anaphylaxis Treatment Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Parenteral

8.2.1 Overview
8.2.2 Parenteral: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Anaphylaxis Treatment Market Analysis – by Allergy Type

9.1 Food Allergy

9.1.1 Overview
9.1.2 Parenteral: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Medications

9.2.1 Overview
9.2.2 Parenteral: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Insect Stings

9.3.1 Overview
9.3.2 Parenteral: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Anaphylaxis Treatment Market – Europe Analysis

10.1 Europe

10.1.1 Europe Anaphylaxis Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Anaphylaxis Treatment Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.1.2 UK: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.1.3 UK: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

10.1.1.2 Germany: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.2.2 Germany: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.2.3 Germany: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

10.1.1.3 France: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.3.2 France: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.3.3 France: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

10.1.1.4 Russia: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.4.2 Russia: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.4.3 Russia: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

10.1.1.5 Italy: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.5.2 Italy: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.5.3 Italy: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

10.1.1.6 Rest of Europe: Europe Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Anaphylaxis Treatment Market Breakdown, by Medication Type
10.1.1.6.2 Rest of Europe: Europe Anaphylaxis Treatment Market Breakdown, by Route of Administration
10.1.1.6.3 Rest of Europe: Europe Anaphylaxis Treatment Market Breakdown, by Allergy Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Anaphylaxis Treatment Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Amneal Pharmaceuticals Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Mylan N.V.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Abbott

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Pfizer Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Glaxosmithkline Plc.,

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck And Co., Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Teva Pharmaceutical Industries Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 ALK-ABELLó

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 BIOPROJET

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights